These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25638324)

  • 1. Systemic treatment of hyperhidrosis.
    del Boz J
    Actas Dermosifiliogr; 2015 May; 106(4):271-7. PubMed ID: 25638324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Systemic Therapies to Manage Focal Hyperhidrosis.
    Glaser DA; Glaser K
    Mo Med; 2015; 112(4):287-91. PubMed ID: 26455059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical Anticholinergics in the Management of Focal Hyperhidrosis in Adults and Children. A Narrative Review.
    Morgado-Carrasco D; de Lucas R
    Actas Dermosifiliogr; 2024 Apr; 115(4):356-367. PubMed ID: 37714301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis.
    Nwannunu CE; Limmer AL; Coleman K; Shah R; Patel RR; Mui UN; Tyring SK
    Skin Therapy Lett; 2019 Mar; 24(2):1-3. PubMed ID: 30970203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of oral glycopyrronium bromide in hyperhidrosis.
    Bajaj V; Langtry JA
    Br J Dermatol; 2007 Jul; 157(1):118-21. PubMed ID: 17459043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating hyperhidrosis. Anticholinergic drugs were not mentioned.
    Klaber M; Catterall M
    BMJ; 2000 Sep; 321(7262):703. PubMed ID: 11202933
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical glycopyrrolate for patients with facial hyperhidrosis.
    Kim WO; Kil HK; Yoon KB; Yoon DM
    Br J Dermatol; 2008 May; 158(5):1094-7. PubMed ID: 18294315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral medications.
    Glaser DA
    Dermatol Clin; 2014 Oct; 32(4):527-32. PubMed ID: 25152346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary Experience with Transdermal Oxybutynin Patches for Hyperhidrosis.
    Bergón-Sendín M; Pulido-Pérez A; Sáez-Martín LC; Suárez-Fernández R
    Actas Dermosifiliogr; 2016 Dec; 107(10):845-850. PubMed ID: 27497508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based review of the nonsurgical management of hyperhidrosis.
    Reisfeld R; Berliner KI
    Thorac Surg Clin; 2008 May; 18(2):157-66. PubMed ID: 18557589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of primary hyperhidrosis with oral anticholinergic medications: a systematic review.
    Cruddas L; Baker DM
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):952-963. PubMed ID: 27976476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis.
    Paller AS; Shah PR; Silverio AM; Wagner A; Chamlin SL; Mancini AJ
    J Am Acad Dermatol; 2012 Nov; 67(5):918-23. PubMed ID: 22405644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigational topical anticholinergics in clinical development for the treatment of hyperhidrosis.
    Gregoriou S; Campanati A; Rigopoulos D; Maria Offidani A; Stratigos A; Kontochristoulos G
    Expert Opin Investig Drugs; 2021 May; 30(5):479-482. PubMed ID: 33691553
    [No Abstract]   [Full Text] [Related]  

  • 14. Qbrexza - A glycopyrronium cloth for axillary hyperhidrosis.
    Med Lett Drugs Ther; 2019 Jan; 61(1564):10-11. PubMed ID: 30856158
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical therapies in hyperhidrosis care.
    Pariser DM; Ballard A
    Dermatol Clin; 2014 Oct; 32(4):485-90. PubMed ID: 25152341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Primary Craniofacial Hyperhidrosis: A Systematic Review.
    Nicholas R; Quddus A; Baker DM
    Am J Clin Dermatol; 2015 Oct; 16(5):361-70. PubMed ID: 26055729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine.
    Walling HW
    J Am Acad Dermatol; 2012 Mar; 66(3):387-92. PubMed ID: 21820204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival study of treatment adherence by patients given oral glycopyrrolate for hyperhidrosis following treatment failure with oral oxybutynin.
    Del Boz J; García-Souto F; Rivas-Ruiz F; Polo-Padillo J
    Dermatol Ther; 2020 Nov; 33(6):e14210. PubMed ID: 32827198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology, toxicology and clinical safety of glycopyrrolate.
    Chabicovsky M; Winkler S; Soeberdt M; Kilic A; Masur C; Abels C
    Toxicol Appl Pharmacol; 2019 May; 370():154-169. PubMed ID: 30905688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral glycopyrrolate for refractory pediatric and adolescent hyperhidrosis.
    Kumar MG; Foreman RS; Berk DR; Bayliss SJ
    Pediatr Dermatol; 2014; 31(1):e28-30. PubMed ID: 24266878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.